Comparison of bromocriptine and hydroxyethyl starch in the prevention of ovarian hyperstimulation syndrome
Authors:
Open Access
- 5 June 2022
- journal article
- research article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 159 (3) , 944-950
Abstract
Objective: To evaluate the effectiveness of bromocriptine for prevention of ovarian hyperstimulation syndrome (OHSS). Methods: The retrospective study included women at risk of OHSS who were receiving gonadotropin‐releasing hormone antagonist protocols, including 52 women given 2.5 mg bromocriptine by rectal insertion, 52 women given 500 ml intravenous hydroxyethyl starch (HES), and 40 women who received no intervention. Treatments were administered daily for 5 days beginning on the day of oocyte retrieval. Baseline information and data related to OHSS were compared. Results: No significant differences were found among groups in estradiol concentration on the day of trigger or in number of retrieved oocytes. Incidence of mild OHSS was not significantly different among groups, respectively 13.5%, 15.4%, and 17.5% ( P > 0.05). The incidence of moderate to severe OHSS was significantly lower in the bromocriptine and HES groups compared with the control group, respectively 7.7%, 5.8%, and 22.5% ( P < 0.05). D‐dimer levels were significantly lower in the bromocriptine and HES groups compared with the control group on Day 5 after oocyte retrieval ( P < 0.05). No differences in liver or renal function were found in the three groups. Conclusion: Bromocriptine was apparently as effective as intravenous HES in patients with high risk of OHSS.Keywords
Funding Information
- Beijing Municipal Administration of Hospitals (PX2019053)
This publication has 22 references indexed in Scilit:
- The effects of bromocriptine on VEGF, kidney function and ovarian hyperstimulation syndrome inin vitrofertilization patients: a pilot studyGynecological Endocrinology, 2012
- Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatmentReproductive Biology and Endocrinology, 2012
- Preventing ovarian hyperstimulation syndrome: guidance for the clinicianFertility and Sterility, 2010
- Ovarian hyperstimulation syndrome: steps to maximize success and minimize effect for assisted reproductive outcomeFertility and Sterility, 2010
- Low-dose aspirin therapy to prevent ovarian hyperstimulation syndromeFertility and Sterility, 2010
- Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? A systematic review and meta-analysisHuman Reproduction Update, 2010
- Ovarian hyperstimulation syndrome: pathophysiology and preventionJournal of Assisted Reproduction and Genetics, 2010
- Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndromeHuman Reproduction Update, 2008
- Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cyclesFertility and Sterility, 2006
- Hemodynamic, blood volume, and oxygen transport responses to albumin and hydroxyethyl starch infusions in critically ill postoperative patientsCritical Care Medicine, 1980